| |
| |
|
| Insider
Information: |
Duggan Robert W |
| Relationship: |
Chief Executive Office... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
594,894,754 |
|
|
Indirect Shares
|
1,046,059 |
|
|
| Direct
Value |
$2,741,810,428 |
|
|
|
Indirect Value
|
$6,593,842 |
|
|
| Total
Shares |
595,940,813 |
|
|
| Total
Value |
$2,748,404,270 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
19
|
0
|
|
Stock
price went up :
|
5
|
0
|
| Stock
price went down : |
14
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -0.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Intuitive Surgical Inc |
ISRG |
Director |
2011-05-18 |
1,000 |
2011-02-09 |
0 |
Premium* |
|
|
Pharmacyclics Inc |
PCYC |
Chairman and CEO, Dire... |
2015-05-26 |
0 |
2015-05-26 |
0 |
Premium* |
|
|
Pulse Biosciences, Inc. |
PLSE |
Director, 10% Owner |
2023-12-12 |
36,984,179 |
2023-12-12 |
843,634 |
Premium* |
|
|
Achaogen Inc |
AKAO |
10% Owner |
2019-03-20 |
5,555,414 |
2019-03-20 |
202,425 |
Premium* |
|
|
Summit Therapeutics Inc |
SMMT |
Chief Executive Office... |
2023-03-06 |
552,354,161 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
318 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 13
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-04-27 |
4 |
B |
$12.96 |
$1,333,160 |
D/D |
102,849 |
7,181,002 |
2.45 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-05-03 |
4 |
B |
$11.43 |
$1,492,654 |
I/I |
130,255 |
100,255 |
1.5 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-05-03 |
4 |
B |
$11.31 |
$9,579,477 |
D/D |
846,625 |
8,027,627 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
– • • |
2018-05-11 |
4 |
B |
$23.16 |
$494,535 |
D/D |
21,353 |
5,862,422 |
3.92 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-11-19 |
4 |
B |
$1.62 |
$7,525 |
D/D |
4,648 |
8,032,275 |
2.37 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-11-20 |
4 |
B |
$1.93 |
$446,947 |
D/D |
231,495 |
8,263,770 |
2.45 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-11-23 |
4 |
B |
$1.89 |
$151,643 |
D/D |
80,175 |
8,343,945 |
2.45 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-11-27 |
4 |
B |
$1.68 |
$129,963 |
D/D |
77,585 |
8,421,530 |
2.45 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-12-07 |
4 |
B |
$1.40 |
$31,394 |
D/D |
22,431 |
8,443,961 |
2.37 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-12-10 |
4 |
B |
$1.60 |
$697,789 |
D/D |
436,500 |
8,880,461 |
2.45 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-12-11 |
4 |
B |
$1.65 |
$505,010 |
D/D |
306,848 |
9,187,309 |
2.45 |
- |
|
| SMMT |
Summit Therapeutics Inc |
Chief Executive Officer |
• • • |
2020-11-06 |
4 |
B |
$3.34 |
$46,999,999 |
D/D |
14,071,856 |
56,296,533 |
3.23 |
% |
|
| SMMT |
Summit Therapeutics Inc |
Chief Executive Officer |
• • • |
2021-05-12 |
4 |
B |
$5.24 |
$59,557,426 |
D/D |
11,365,921 |
67,662,454 |
3.23 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
– • • |
2021-06-30 |
4 |
B |
$16.40 |
$49,999,992 |
D/D |
3,048,780 |
14,708,561 |
3.92 |
% |
|
| SMMT |
Summit Therapeutics Inc |
Chief Executive Officer |
• • – |
2022-08-16 |
4 |
B |
$0.97 |
$92,003,727 |
D/D |
94,849,203 |
162,532,792 |
2.81 |
% |
|
| SMMT |
Summit Therapeutics Inc |
Chief Executive Officer |
• • – |
2023-03-06 |
4 |
B |
$1.05 |
$395,314,374 |
D/D |
376,489,880 |
552,354,161 |
2.81 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
– • • |
2023-05-09 |
4 |
B |
$6.51 |
$65,249,320 |
D/D |
10,022,937 |
30,414,661 |
3.92 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-11-17 |
4 |
B |
$6.09 |
$123,470 |
D/D |
20,241 |
36,266,797 |
3.92 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-11-28 |
4 |
B |
$8.98 |
$1,117,085 |
D/D |
124,397 |
36,391,194 |
3.92 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-11-29 |
4 |
B |
$9.44 |
$1,497,184 |
D/D |
158,600 |
36,551,461 |
3.92 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-11-29 |
4 |
B |
$9.21 |
$552,600 |
I/I |
60,000 |
60,000 |
2.25 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-11-30 |
4 |
B |
$9.06 |
$1,385,673 |
I/I |
152,944 |
212,944 |
2.25 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-01 |
4 |
B |
$9.07 |
$413,592 |
I/I |
45,600 |
258,544 |
2.25 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-04 |
4 |
B |
$10.38 |
$280,260 |
I/I |
27,000 |
285,544 |
2.25 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-05 |
4 |
B |
$9.34 |
$616,636 |
I/I |
66,021 |
351,565 |
2.25 |
% |
|
318 Records found
|
|
Page 5 of 13 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
